
Sinatra Sang Bacharach—But Only Twice
By WILL FRIEDWALD
|The Biden administration could be backing away from its full embrace of the ‘Harm Reduction’ approach to drug use.

Is the Biden administration backing away from its tenuous support for supervised injection sites? The Department of Justice’s latest move regarding Philadelphia’s contentious Safehouse supervised injection site case indicates so — and reelection politics are likely at play.

By WILL FRIEDWALD
|
By MARIO NAVES
|
By GARY GASTELU
|
By ROSS ANDERSON
|
By JOSEPH CURL
|
By DAVID JONES
|
By A.R. HOFFMAN
|
By GEORGE WILLIS
|Is the Biden administration backing away from its tenuous support for supervised injection sites? The Department of Justice’s latest move regarding Philadelphia’s contentious Safehouse supervised injection site case indicates so — and reelection politics are likely at play.
Already have a subscription? Sign in to continue reading
Cancel anytime
By continuing you agree to our Privacy Policy and Terms of Service.
Cancel anytime